Title |
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trial |
|---|---|
Involved |
Georg Heß (Verfasser)
Andreas Hüttmann (Verfasser) Mathias Witzens-Harig (Verfasser) Martin Dreyling (Verfasser)
Ulrich Keller (Verfasser)
Reinhard Marks (Verfasser) Thomas Ernst (Verfasser) Christiane Pott (Verfasser) Andreas Viardot (Verfasser) Fabian Frontzek (Verfasser) Marcel Trautmann (Verfasser) Christian Ruckes (Verfasser) Oliver Deuster (Verfasser) Andreas Rosenwald (Verfasser) Matthias Theobald (Verfasser) Georg Lenz (Verfasser) |
Published |
Freiburg: Universität |
Extent |
Online-Ressource |
Language |
|
Country |
|
Topic |
|
Subject |
Hematology |
DDC notation |
|
Persistent identifier |
urn:nbn:de:bsz:25-freidok-2266869 (URN) |
Further information |
British journal of haematology. - 198, 3 (2022) , 482-491, ISSN: 1365-2141 |
Record ID |
127268797X |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: